Bioxyne Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other companies in this sector in AUSTRALIA : Amplia Therapeutics Ltd (2021 sales of 1.53 million Australian Dollars [US$1.11 million] ), Zelira Therapeutics Ltd (2.09 million Australian Dollars [US$1.52 million] of which 27% was USA), and Invion Limited (2.33 million Australian Dollars [US$1.69 million] of which 100% was Drug Development).

Sales Analysis. During the year ended June of 2021, sales at Bioxyne Limited were A$2.11 million (US$1.53 million). This is a decrease of 6.6% versus 2020, when the company's sales were A$2.26 million. The sales level in 2021 was fairly close to the level five years ago: in 2016, Bioxyne Limited had sales of A$1.92 million.